Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
2.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol
; 24(7): 811-822, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414012
3.
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.
Cancer Immunol Immunother
; 72(2): 385-395, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907016
4.
Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients.
Cancer Immunol Immunother
; 72(2): 437-448, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931835
5.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
6.
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.
J Cell Mol Med
; 26(24): 5976-5983, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453136
7.
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia.
Br J Haematol
; 197(3): 306-309, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149986
8.
The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model.
Blood
; 134(15): 1247-1256, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395601
9.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Blood
; 133(15): 1652-1663, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728140
10.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
11.
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy.
Br J Haematol
; 189(6): 1119-1126, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030732
12.
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies.
Blood
; 131(6): 611-620, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158362
13.
Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective.
J Cell Physiol
; 234(5): 5827-5841, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30317583
14.
Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells.
J Cell Physiol
; 234(6): 9207-9215, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362586
15.
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.
Br J Haematol
; 186(2): 255-262, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044423
16.
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma.
Biol Blood Marrow Transplant
; 24(2): 282-287, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061536
17.
Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma.
Curr Treat Options Oncol
; 19(9): 45, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30032463
18.
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
Blood
; 125(13): 2111-9, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628467
19.
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
Biol Blood Marrow Transplant
; 22(2): 380-385, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26348890
20.
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
Br J Haematol
; 172(2): 208-18, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26492567